Correlation between metabolic dysfunction-associated steatotic liver disease and subclinical coronary atherosclerosis in eastern China
Abstract Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by the presence of at least one cardiovascular disease (CVD) risk factor, underscoring its potential to elevate CVD risk in affected individuals. However, evidence linking MASLD to subclinical coron...
Saved in:
Main Authors: | Guanghui Ma, Guohou Xu, Haixia Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Diabetology & Metabolic Syndrome |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13098-025-01577-z |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diagnostic Potential of CTRP5 and Chemerin for Coronary Artery Disease: A Study by Coronary Computed Tomography Angiography
by: Taha Okan, et al.
Published: (2025-01-01) -
Osteopontin as a Biomarker for Coronary Artery Disease
by: Georgia R. Layton, et al.
Published: (2025-01-01) -
Breast Arterial Calcification on a Screening Mammogram: A Potential Cardiovascular Risk Stratification Tool in Women
by: Ahmed Fathala, et al.
Published: (2024-12-01) -
Flow Mediated Dilation and Its Correlation with Coronary and Systemic Atherosclerosis in Patients Scheduled for Surgical Myocardial Revascularization
by: Boieriu AM, et al.
Published: (2025-02-01) -
Systematic Coronary Risk Evaluation 2 (SCORE2), arterial stiffness, and subclinical coronary atherosclerosis in a population-based study
by: Susanna Strömberg, et al.
Published: (2025-01-01)